144 related articles for article (PubMed ID: 28290105)
1. Economic Evaluations of Thrombophilia Screening Prior to Prescribing Combined Oral Contraceptives: A Systematic and Critical Review.
Vernon E; Hiedemann B; Bowie BH
Appl Health Econ Health Policy; 2017 Oct; 15(5):583-595. PubMed ID: 28290105
[TBL] [Abstract][Full Text] [Related]
2. Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study.
Wu O; Robertson L; Twaddle S; Lowe GD; Clark P; Greaves M; Walker ID; Langhorne P; Brenkel I; Regan L; Greer I
Health Technol Assess; 2006 Apr; 10(11):1-110. PubMed ID: 16595080
[TBL] [Abstract][Full Text] [Related]
3. Can a change in screening and prescribing practice reduce the risk of venous thromboembolism in women taking the combined oral contraceptive pill?
Mills A; Wilkinson C; Fotherby K
Br J Fam Plann; 1998 Jan; 23(4):112-5. PubMed ID: 9882763
[TBL] [Abstract][Full Text] [Related]
4. A systematic review of cost-effectiveness analysis of screening interventions for assessing the risk of venous thromboembolism in women considering combined oral contraceptives.
Ademi Z; Sutherland CS; Van Stiphout J; Michaud J; Tanackovic G; Schwenkglenks M
J Thromb Thrombolysis; 2017 Nov; 44(4):494-506. PubMed ID: 28918448
[TBL] [Abstract][Full Text] [Related]
5. Re-Examining Genetic Screening and Oral Contraceptives: A Patient-Centered Review.
Hiedemann B; Vernon E; Bowie BH
J Pers Med; 2019 Jan; 9(1):. PubMed ID: 30650548
[TBL] [Abstract][Full Text] [Related]
6. Is screening for thrombophilia cost-effective?
Wu O; Greer IA
Curr Opin Hematol; 2007 Sep; 14(5):500-3. PubMed ID: 17934357
[TBL] [Abstract][Full Text] [Related]
7. Screening for thrombophilia in high-risk situations: a meta-analysis and cost-effectiveness analysis.
Wu O; Robertson L; Twaddle S; Lowe G; Clark P; Walker I; Brenkel I; Greaves M; Langhorne P; Regan L; Greer I;
Br J Haematol; 2005 Oct; 131(1):80-90. PubMed ID: 16173967
[TBL] [Abstract][Full Text] [Related]
8. Thrombophilia in young women candidate to the pill: reasons for and against screening.
Cosmi B; Coccheri S
Pathophysiol Haemost Thromb; 2002; 32(5-6):315-7. PubMed ID: 13679664
[TBL] [Abstract][Full Text] [Related]
9. Does use of hormonal contraceptives among women with thrombogenic mutations increase their risk of venous thromboembolism? A systematic review.
Mohllajee AP; Curtis KM; Martins SL; Peterson HB
Contraception; 2006 Feb; 73(2):166-78. PubMed ID: 16413847
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for venous thromboembolism in women under combined oral contraceptive. The PILl Genetic RIsk Monitoring (PILGRIM) Study.
Suchon P; Al Frouh F; Henneuse A; Ibrahim M; Brunet D; Barthet MC; Aillaud MF; Venton G; Alessi MC; Trégouët DA; Morange PE
Thromb Haemost; 2016 Jan; 115(1):135-42. PubMed ID: 26290123
[TBL] [Abstract][Full Text] [Related]
11. Thrombotic risks of oral contraceptives.
Rott H
Curr Opin Obstet Gynecol; 2012 Aug; 24(4):235-40. PubMed ID: 22729096
[TBL] [Abstract][Full Text] [Related]
12. Oral contraception in women with mild thrombophilia: what have we learned recently?
Blanco-Molina Á
Thromb Res; 2012 Oct; 130 Suppl 1():S16-8. PubMed ID: 23026651
[TBL] [Abstract][Full Text] [Related]
13. Thrombophilia testing in people with venous thromboembolism: systematic review and cost-effectiveness analysis.
Simpson EL; Stevenson MD; Rawdin A; Papaioannou D
Health Technol Assess; 2009 Jan; 13(2):iii, ix-x, 1-91. PubMed ID: 19080721
[TBL] [Abstract][Full Text] [Related]
14. Combined hormonal contraception and venous thromboembolism.
Martínez F; Avecilla A
Eur J Contracept Reprod Health Care; 2007 Jun; 12(2):97-106. PubMed ID: 17559006
[TBL] [Abstract][Full Text] [Related]
15. Contraception-related venous thromboembolism in adolescents.
O'Brien SH
Semin Thromb Hemost; 2014 Feb; 40(1):66-71. PubMed ID: 24356931
[TBL] [Abstract][Full Text] [Related]
16. [Risk of thrombosis with oral contraceptives: value of a thrombophilia screening test].
Bauersachs R; Kuhl H; Lindhoff-Last E; Ehrly AM
Vasa; 1996; 25(3):209-20. PubMed ID: 8967151
[TBL] [Abstract][Full Text] [Related]
17. Oral contraceptives and the absolute risk of venous thromboembolism in women with single or multiple thrombophilic defects: results from a retrospective family cohort study.
van Vlijmen EF; Brouwer JL; Veeger NJ; Eskes TK; de Graeff PA; van der Meer J
Arch Intern Med; 2007 Feb; 167(3):282-9. PubMed ID: 17296885
[TBL] [Abstract][Full Text] [Related]
18. Oral contraceptives and venous thromboembolism: consensus conference statement.
Dialogues in Contraception Consensus Conference (1995: Chicago)
Dialogues Contracept; 1996; ():1-8. PubMed ID: 12320455
[TBL] [Abstract][Full Text] [Related]
19. Hormonal contraceptives as a risk factor for cerebral venous and sinus thrombosis.
Saadatnia M; Tajmirriahi M
Acta Neurol Scand; 2007 May; 115(5):295-300. PubMed ID: 17489938
[TBL] [Abstract][Full Text] [Related]
20. Consequences of thrombophilia screening for life quality in women before prescription of oral contraceptives and family members of VTE patients.
Eichinger S
Hamostaseologie; 2009 Jan; 29(1):110-1. PubMed ID: 19151859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
